GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Endoscopy/Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026
20

Durable Endoscopic Partial Reversal of Roux-en-Y Gastric Bypass Using Parallel LAMS Septotomy: GIE | July 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated July 1, 2026

Introduction:

Although Roux-en-Y gastric bypass (RYGB) is an effective bariatric procedure, a small proportion of patients develop severe nutritional complications, refractory dumping syndrome, or other debilitating adverse events requiring reversal. This study describes a novel endoscopic technique that offers a minimally invasive alternative to surgical reversal.

Why was this technique needed?

Surgical reversal of RYGB carries substantial morbidity, particularly in malnourished or medically complex patients. Conventional EUS-guided gastrogastric fistulas created with lumen-apposing metal stents (LAMS) often close after stent removal, limiting long-term success.

What did the study show?

  • Six patients underwent endoscopic partial RYGB reversal using the parallel LAMS septotomy technique.
  • Technical and clinical success was achieved in 100% of patients.
  • Durable gastrogastric anastomosis was maintained after stent removal in all patients during follow-up.
  • No major procedure-related adverse events were reported.
  • The technique eliminates the need for permanent indwelling LAMS while maintaining long-term luminal patency.
  • Patients experienced sustained restoration of gastric continuity without requiring surgical reversal.

Clinical Impact:

Parallel LAMS septotomy represents an important advance in third-space endoscopy, providing a minimally invasive option for selected patients requiring RYGB reversal. The technique may reduce surgical morbidity while offering durable anatomical restoration.

Take-Home Message:

Parallel LAMS septotomy enables durable endoscopic partial reversal of Roux-en-Y gastric bypass without permanent stent dependence. Although early results are highly encouraging, larger studies with longer follow-up are needed before widespread adoption.

Related Q&A

21

EUS Double Drainage for Malignant Dual Obstruction : Gut | Jul 2026

Introduction: Simultaneous malignant distal biliary obstruction (MDBO) and gastric outlet obstruction (GOO), commonly caused by advanced pancreatic, biliary, or duodenal cancers, presents a major palliative challenge. Conventional endoscopic...

22

Endoscopic Mucosal and Submucosal Cutting in benign esophageal stricture: Gut | July 2026

Introduction: Long benign esophageal strictures remain one of the most difficult benign conditions to manage. Although endoscopic dilation and incision techniques provide temporary relief, recurrence is common, often...

23

Economic Impact of POEM and ESD: GIE | June 2026

Introduction: Peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD) have revolutionized the management of esophageal motility disorders and early gastrointestinal neoplasia. Despite their proven clinical benefits, widespread...

24

Remimazolam Improves Sedation Safety During ERCP : GIE | Jun 2026

Introduction: Deep sedation is essential for successful endoscopic retrograde cholangiopancreatography (ERCP), a technically complex procedure frequently performed in elderly patients and those with significant comorbidities. Propofol remains the...

25

Sustainability Cuts Endoscopy Carbon Footprint and Costs : GIE | Jun 2026

Introduction: Endoscopy services generate substantial amounts of healthcare waste due to high procedural volumes, extensive use of disposable accessories, and stringent infection-control requirements. As healthcare systems increasingly focus...

26

Modern Endoscopic Management of Flat Colonic Neoplasia : Endoscopy | June 2026

Introduction: Non-pedunculated colonic neoplasia (NPCN), including flat and sessile colorectal lesions, is being detected with increasing frequency due to widespread colorectal cancer screening and advances in high-definition endoscopy....

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer